title: Effect of selective heparin desulfation on preservation of bone morphogenetic protein-2 bioactivity after thermal stress.
abstract: Bone morphogenetic protein-2 (BMP-2) plays an important role in bone and cartilage formation and is of interest in regenerative medicine. Heparin can interact electrostatically with BMP-2 and thus has been explored for controlled release and potential stabilization of this growth factor in vivo. However, in its natively sulfated state, heparin has potent anticoagulant properties that may limit its use. Desulfation reduces anticoagulant properties, but may impact heparin's ability to interact and protect BMP-2 from denaturation. The goal of this study was to characterize three selectively desulfated heparin species (N-desulfated (Hep(-N)), 6-O,N-desulfated (Hep(-N,-6O)), and completely desulfated heparin (Hep(-))) and determine if the sulfation level of heparin affected the level of BMP-2 bioactivity after heat treatment at 65 °C. BMP-2 bioactivity was evaluated using the established C2C12 cell assay. The resulting alkaline phosphatase activity data demonstrated that native heparin maintained a significant amount of BMP-2 bioactivity and the effect appeared to be heparin concentration dependent. Although all three had the same molecular charge as determined by zeta potential measurements, desulfated heparin derivatives Hep(-N) and Hep(-N,-6O) were not as effective as native heparin in maintaining BMP-2 bioactivity (only ~35% of original activity remained in both cases). These findings can be used to better select desulfated heparin species that exhibit low anticoagulant activity while extending the half-life of BMP-2 in solution and in delivery systems.
authors.affiliation: W.H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University , 315 Ferst Drive, Atlanta, Georgia 30332, United States.
authors.forename: Song P
authors.initials: SP
authors.lastname: Seto
authors.forename: Tobias
authors.initials: T
authors.lastname: Miller
authors.forename: Johnna S
authors.initials: JS
authors.lastname: Temenoff
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000737:chemistry* / Q000378:metabolism*; D055396:Bone Morphogenetic Protein 2 / Q000008:administration & dosage / Q000737:chemistry / Q000378:metabolism*; D002460:Cell Line; D004337:Drug Carriers / Q000737:chemistry / Q000378:metabolism; D006493:Heparin / Q000737:chemistry* / Q000378:metabolism*; D006358:Hot Temperature; D006801:Humans; D051379:Mice; D011489:Protein Denaturation / Q000187:drug effects; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000737:chemistry / Q000378:metabolism; D013455:Sulfur / Q000302:isolation & purification*
chemical_list: D000925:Anticoagulants; D055396:Bone Morphogenetic Protein 2; D004337:Drug Carriers; D011994:Recombinant Proteins; D013455:Sulfur; D006493:Heparin